These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

214 related articles for article (PubMed ID: 21091683)

  • 1. Topical nadifloxacin 1% cream vs. topical erythromycin 4% gel in the treatment of mild to moderate acne.
    Tunca M; Akar A; Ozmen I; Erbil H
    Int J Dermatol; 2010 Dec; 49(12):1440-4. PubMed ID: 21091683
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Efficacy of combined topical treatment of acne vulgaris with adapalene and nadifloxacin: a randomized study.
    Kobayashi M; Nakagawa T; Fukamachi K; Nakamura M; Tokura Y
    J Dermatol; 2011 Dec; 38(12):1163-6. PubMed ID: 22007904
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Lack of irritative potential of nadifloxacin 1% when combined with other topical anti-acne agents.
    Wilhelm KP; Wilhelm D; Neumeister C; Zsolt I; Schwantes U
    Clin Exp Dermatol; 2012 Mar; 37(2):112-7. PubMed ID: 22103435
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Clinical and bacteriological evaluation of nadifloxacin 1% cream in patients with acne vulgaris: a double-blind, phase III comparison study versus erythromycin 2% cream.
    Plewig G; Holland KT; Nenoff P
    Eur J Dermatol; 2006; 16(1):48-55. PubMed ID: 16436342
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Clinical and histological evaluation of 1% nadifloxacin cream in the treatment of acne vulgaris in Korean patients.
    Jung JY; Kwon HH; Yeom KB; Yoon MY; Suh DH
    Int J Dermatol; 2011 Mar; 50(3):350-7. PubMed ID: 21342170
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical evaluation of Double Strength Isotrexin versus Benzamycin in the topical treatment of mild to moderate acne vulgaris.
    Marazzi P; Boorman GC; Donald AE; Davies HD
    J Dermatolog Treat; 2002 Sep; 13(3):111-7. PubMed ID: 12227873
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conjoint analysis: a novel, rigorous tool for determining patient preferences for topical antibiotic treatment for acne. A randomised controlled trial.
    Kellett N; West F; Finlay AY
    Br J Dermatol; 2006 Mar; 154(3):524-32. PubMed ID: 16445786
    [TBL] [Abstract][Full Text] [Related]  

  • 8. A topical azithromycin preparation for the treatment of acne vulgaris and rosacea.
    McHugh RC; Rice A; Sangha ND; McCarty MA; Utterback R; Rohrback JM; Osborne BE; Fleischer AB; Feldman SR
    J Dermatolog Treat; 2004 Sep; 15(5):295-302. PubMed ID: 15370397
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct analysis of resistance in the cutaneous microflora during treatment of acne vulgaris with topical 1% nadifloxacin and 2% erythromycin.
    Bojar RA; Hittel N; Cunliffe WJ; Holland KT
    Drugs; 1995; 49 Suppl 2():164-7. PubMed ID: 8549289
    [No Abstract]   [Full Text] [Related]  

  • 10. Nadifloxacin: a quinolone for topical treatment of skin infections and potential for systemic use of its active isomer, WCK 771.
    Jacobs MR; Appelbaum PC
    Expert Opin Pharmacother; 2006 Oct; 7(14):1957-66. PubMed ID: 17020421
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Benzoyl peroxide: enhancing antibiotic efficacy in acne management.
    Dutil M
    Skin Therapy Lett; 2010; 15(10):5-7. PubMed ID: 21076800
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Tretinoin gel microspheres 0.04% versus 0.1% in adolescents and adults with mild to moderate acne vulgaris: a 12-week, multicenter, randomized, double-blind, parallel-group, phase IV trial.
    Berger R; Rizer R; Barba A; Wilson D; Stewart D; Grossman R; Nighland M; Weiss J
    Clin Ther; 2007 Jun; 29(6):1086-97. PubMed ID: 17692723
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Topical taurine bromamine, a new candidate in the treatment of moderate inflammatory acne vulgaris: a pilot study.
    Marcinkiewicz J; Wojas-Pelc A; Walczewska M; Lipko-Godlewska S; Jachowicz R; Maciejewska A; Białecka A; Kasprowicz A
    Eur J Dermatol; 2008; 18(4):433-9. PubMed ID: 18573718
    [TBL] [Abstract][Full Text] [Related]  

  • 14. A randomized, single-blind comparison of topical clindamycin + benzoyl peroxide (Duac) and erythromycin + zinc acetate (Zineryt) in the treatment of mild to moderate facial acne vulgaris.
    Langner A; Sheehan-Dare R; Layton A
    J Eur Acad Dermatol Venereol; 2007 Mar; 21(3):311-9. PubMed ID: 17309451
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Clinical and bacteriological evaluation of adapalene 0.1% gel plus nadifloxacin 1% cream versus adapalene 0.1% gel in patients with acne vulgaris.
    Takigawa M; Tokura Y; Shimada S; Furukawa F; Noguchi N; Ito T;
    J Dermatol; 2013 Aug; 40(8):620-5. PubMed ID: 23724808
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Efficacy of the fixed 1.2% clindamycin phosphate, 0.025% tretinoin gel formulation (Velac) and a proprietary 0.025% tretinoin gel formulation (Aberela) in the topical control of facial acne.
    Richter JR; Förström LR; Kiistala UO; Jung EG
    J Eur Acad Dermatol Venereol; 1998 Nov; 11(3):227-33. PubMed ID: 9883434
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tazarotene 0.1 percent cream plus clindamycin 1 percent gel versus tretinoin 0.025 percent gel plus clindamycin 1 percent gel in the treatment of facial acne vulgaris.
    Tanghetti E; Dhawan S; Torok H; Kircik L
    Dermatol Online J; 2007 Jul; 13(3):1. PubMed ID: 18328195
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Combination of azelaic acid 5% and erythromycin 2% in the treatment of acne vulgaris.
    Pazoki-Toroudi H; Nassiri-Kashani M; Tabatabaie H; Ajami M; Habibey R; Shizarpour M; Babakoohi S; Rahshenas M; Firooz A
    J Dermatolog Treat; 2010 May; 21(3):212-6. PubMed ID: 20394495
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Clinical assessment of topical erythromycin gel with and without zinc acetate for treating mild-to-moderate acne vulgaris.
    Sayyafan MS; Ramzi M; Salmanpour R
    J Dermatolog Treat; 2020 Nov; 31(7):730-733. PubMed ID: 30998422
    [No Abstract]   [Full Text] [Related]  

  • 20. Effects of tazarotene 0.1 % cream in the treatment of facial acne vulgaris: pooled results from two multicenter, double-blind, randomized, vehicle-controlled, parallel-group trials.
    Shalita AR; Berson DS; Thiboutot DM; Leyden JJ; Parizadeh D; Sefton J; Walker PS; Gibson JR;
    Clin Ther; 2004 Nov; 26(11):1865-73. PubMed ID: 15639698
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.